𝔖 Bobbio Scriptorium

✦ LIBER ✦

Knocking-Out Concentrations of HIV-1-Specific Inhibitors Completely Suppress HIV-1 Infection and Prevent the Emergence of Drug-Resistant Virus

✍ Scribed by Jan Balzarini; Anna Karlsson; Maria-Jésus Pérez-Pérez; Maria-José Camarasa; Erik De Clercq

Book ID: 112269364
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 855 KB
Volume: 196
Category: Article
ISSN: 0042-6822
DOI: 10.1006/viro.1993.1513

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New Developments in the Chemotherapy of

New Developments in the Chemotherapy of Lentivirus (Human Immunodeficiency Virus) Infections: Sensitivity/Resistance of HIV-1 to Non-nucleoside HIV-1-specific Inhibitors : CHEMOTHERAPY OF HIV INFECTIONS

✍ ERIK DE CLERCQ 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 957 KB

Characterizing the emergence and persist

Characterizing the emergence and persistence of drug resistant mutations in HIV-1 subtype C infections using 454 ultra deep pyrosequencing

✍ Vijay Bansode, Grace P McCormack, Amelia C Crampin… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 197 KB

ChemInform Abstract: Non-Nucleoside Reve

ChemInform Abstract: Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) for the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections: Strategies to Overcome Drug Resistance Development

✍ E. DE CLERCQ 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 25 KB

Selective Pressure of a Quinoxaline Nonn

Selective Pressure of a Quinoxaline Nonnucleoside Inhibitor of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase (RT) on HIV-1 Replication Results in the Emergence of Nucleoside RT-Inhibitor-Specific (RT Leu-74 → Val or Ile and Val-75 → Leu or Ile) HIV-1 mutants

✍ Jörg-Peter Kleim, Manfred Rösner, Irvin Winkler, Arno Paessens, Reinhard Kirsch, 📂 Article 📅 1996 🏛 National Academy of Sciences 🌐 English ⚖ 346 KB

140 Effects of combinations of HIV-1 spe

140 Effects of combinations of HIV-1 specific RT inhibitors with complementary resistance profiles on the time and type of drug-resistant HIV-1 development: R. Pauwels1, M.P. de Béthune1, K. Andries2, P. Stoffels2, J. Desmyter1, P.A.J. Janssen2 and E. De Clercq1 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium and 2Janssen Research Foundation, Beerse, Belgium

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 81 KB

The thiocarboxanilides UC-781 and UC-82

The thiocarboxanilides UC-781 and UC-82 are potent HIV-1-specific reverse transcriptase inhibitors that inhibit a broad spectrum of drug-resistant HIV-1 strains: J. Balzarini1, C.-F. Perno2, D. Schols1, M. Witvrouw1, E. De Clercq1 and A. Karlsson3 1Rega Institute for Medical Research, K.U.Leuven, Leuven, Belgium; 2University of Rome “Tor Vergata”, Rome, Italy; 3Karolinska Institute, Stockholm, Sweden

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 111 KB